Client Login

Request Demo

BCBS AL Telehealth and Remote Access Telemedicine Policy

Blue Cross and Blue Shield of Alabama’s Telehealth and Remote Access Telemedicine policy has been updated with information about using appropriate place-of-service codes for telemedicine. Review this policy on ProviderAccess for more information – Telemedicine and Remote Access Webpage

Effective November 1, 2022 – Updated Preferred Drug Changes for Patients with PEEHIP Coverage Pegfilgrastim

Fulphila (pegfilgrastim-jmdb) is now the preferred pegfilgrastim product for PEEHIP patients.

Bevacizumab, Trastuzumab and Rituximab
Effective November 1, 2022, the following are preferred products for PEEHIP patients:

  • Zirabev is the exclusive preferred bevacizumab product for oncologic indications.
  • Trazimera and Ogivri are the exclusive preferred trastuzumab products.
  • Ruxience and Truxima are the exclusive preferred rituximab products.

Information obtained from the latest Provider News – Thursday, Nov 17th –